The Medicines and Healthcare products Regulatory Agency (MHRA) has assessed the risk of nitrosamine formation or presence during the manufacture of human medicines and has provided guidance for manufacturers to avoid the presence of nitrosamine impurities.
The Medicines and Healthcare products Regulatory Agency (MHRA) has assessed the risk of nitrosamine formation or presence during the manufacture of human medicines and has provided guidance for manufacturers to avoid the presence of nitrosamine impurities…
